Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.00000005
recombinant enzyme, crude cell homogenate of transfected NIH 3T3 cells
0.000000051
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells
0.00000007
recombinant enzyme, crude cell homogenate of transfected CHO-K1 cells
0.00000009
testis, crude homogenate, native wild-type
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
-
relative activity: GalNAcalpha: 1.4%, GalNAcbeta: 1.9%, GM2: 38%, lyso-GM2: 0.3%, GA2: 100%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
-
relative activity: GalNAcalpha: 3.0%, GalNAcbeta: 50.5%, GM2: 100%, lyso-GM2: 606%, GA2: 8.8%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
-
relative activity: GalNAcalpha: 6.4%, GalNAcbeta: 47.5%, GM2: 100%, lyso-GM2: 444%, GA2: 29%
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
-
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 158 (substrate: GalNAcalpha), 192 (substrate: GalNAcbeta), 210 (substrate: GM2), 83.5 (substrate: IFNalpha2b)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
-
specific activity of N-term MalE-CgtBOH4384 fusion construct (mU/mg): 9.7 (substrate: GalNAcalpha), 4.8 (substrate: GalNAcbeta), 4.5 (substrate: GM2), 86.9 (substrate: GA2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)
additional information
-
specific activity of N-term MalECgtBOH4384 fusion construct (mU/mg): 13.6 (substrate: GalNAcalpha), 40.4 (substrate: GalNAcbeta), 27 (substrate: GM2)